Explore WARF Inventions and Patents
WARF’s portfolio of more than 1,500 patented technologies covers a wide range of categories, including analytical instrumentation, pharmaceuticals, food products, agriculture, research tools, medical devices, pluripotent stem cells, clean technology, information technology and semiconductors.
Information summaries, which describe each technology and its applications, benefits, inventors and patent status, can be downloaded, printed and shared by clicking on the technology category links to the left on this page.
The new amphiphiles, called CAO, DCAO and LCAO, are effective in challenging biochemical systems, such as extraction of delicate photosynthetic superassemblies from native lipid bilayers.
In the process, a fresh or frozen sample is stained with DNA-binding fluorescent dye and imaged with a microscope. The brightness of the sperm head is averaged and compared with samples of known fertility.
The gel can contain a combination of therapeutic agents like rapamycin, paclitaxel and 17-AAG. After being administered to a patient, the gel releases the drugs at a controlled rate, and then biodegrades into nontoxic fragments.
Drug-eluting stents and other medical devices containing idarubicin (or an analog) could be administered prior to or following a vascular procedure like angioplasty.
Encapsulating hydrophobic and/or fluorophilic compounds with these micelles provides enhanced solubilization, protection and stabilization as compared to conventional drug delivery methods. The fluorophilic block effectively seals the hydrophobic core, making the micelles and therapeutic agents more stable, and can be modified to selectively “tune” the release rate of the encapsulated compound.
Growers interested in this cranberry variety should license the variety from WARF and obtain vines from one of the approved propagators listed below. The license between WARF and the grower must be in place before vines can be obtained.
- Cranberry Creek Cranberries Inc.
- Dempze Cranberry Co.